These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2412422)

  • 1. [Long-term therapy with Robaveron tablet (KN-7) for urinary disturbance].
    Tei K; Doi T; Sakai S; Fujimoto Y; Ban Y
    Hinyokika Kiyo; 1985 Apr; 31(4):731-8. PubMed ID: 2412422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Robaveron tablet (KN-7) in the long-term therapy for urinary disturbances].
    Yamada K; Shiomi T; Momose H; Yamamoto M; Okamura K; Suemori T
    Hinyokika Kiyo; 1985 May; 31(5):901-6. PubMed ID: 4050635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of Robaveron tablet (KN-7) on urinary disturbance by benign prostatic hypertrophy].
    Sonoda T; Endo H; Maru A; Sasaki K; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1985 Mar; 31(3):553-62. PubMed ID: 2411118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative double-blind trial of KN-7 tablet and Robaveron injection in the treatment of neurogenic bladder].
    Sonoda T; Endo H; Kuroda K; Takamura T; Inada F; Ohori T; Kubo T; Suzuki Y; Nakano N; Sato S
    Hinyokika Kiyo; 1984 Apr; 30(4):561-79. PubMed ID: 6385666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of Robaveron tablet (KN-7) on neurogenic bladder].
    Endo H; Sonoda T; Koyanagi T; Maru A; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1984 Jan; 30(1):135-44. PubMed ID: 6375318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy].
    Fukuoka H; Ishibashi Y; Shiba T; Tuchiya F; Sakanishi S
    Hinyokika Kiyo; 1993 Jul; 39(7):679-83. PubMed ID: 7689782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effectiveness of KL 007 (oxybutynin hydrochloride) in urinary disorders].
    Takimoto Y; Kiyotaki S; Kawazoe K; Fuse T; Kitamura K; Yamamoto T; Satoh Y; Okada K; Kishimoto T
    Hinyokika Kiyo; 1985 Dec; 31(12):2284-301. PubMed ID: 3832931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the use of oxybutynin hydrochloride (Pollakisu tablets) in the elderly].
    Uchibayashi T; Nakajima K; Nihino A; Hisazumi H
    Hinyokika Kiyo; 1991 Sep; 37(9):1077-85. PubMed ID: 1785418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects of oxybutynin hydrochloride (Pollakis)--especially in the treatment of pollakisuria, urgency and urinary incontinence].
    Yamauchi K; Ohashi K; Osanai H; Inagaki N; Yamaguchi S; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 1990 Dec; 36(12):1485-90. PubMed ID: 2075888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
    Takita T; Kondo A; Mitsuya H; Otani T
    Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of cernilton in the treatment of the benign prostatic hypertrophy].
    Horii A; Iwai S; Maekawa M; Tsujita M
    Hinyokika Kiyo; 1985 Apr; 31(4):739-46. PubMed ID: 2412423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of terodiline hydrochloride in patients with urinary frequency or incontinence].
    Yasuno H; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Kataoka N; Matsushita M; Inaba Y; Umezu K; Yamashita M
    Hinyokika Kiyo; 1991 Apr; 37(4):431-9. PubMed ID: 1892003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term efficacy of naftopidil for treatment of lower urinary tract symptoms with benign prostatic hyperplasia].
    Akasaka T; Funaki H; Hirano S; Ohinata M; Fujishima M; Kudou T; Suzuki A; Iinuma M
    Hinyokika Kiyo; 2003 Apr; 49(4):189-93. PubMed ID: 12784711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effects of beta-sitosterol (phytosterol) on benign prostatic hyperplasia: preliminary study].
    Kobayashi Y; Sugaya Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):865-8. PubMed ID: 10028431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia.
    Schulman CC; Lock TM; Buzelin JM; Boeminghaus F; Stephenson TP; Talja M;
    J Urol; 2001 Oct; 166(4):1358-63. PubMed ID: 11547074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of Cernilton in benign prostatic hypertrophy].
    Hayashi J; Mitsui H; Yamakawa G; Suga A; Kai A; Shimabukuro T; Yanagi K; Fujisawa S; Takihara H; Kaneda Y
    Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.